Download PDF
Dtsch Med Wochenschr 2011; 136(48): 2466-2469
DOI: 10.1055/s-0031-1297268
Hämatologie und Onkologie | Commentary
Hämatologie
© Georg Thieme Verlag KG Stuttgart · New York

Akute lymphatische Leukämie des Erwachsenen

Acute lymphoblastic leukemia in the adultN. Gökbuget1
  • 1Medizinische Klinik II, Johann Wolfgang Goethe-Universität Frankfurt
Further Information

Publication History

Publication Date:
22 November 2011 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Akute lymphatische Leukämie

Keywords

acute lymphoblastic

Literatur

  • 1 Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia.  J Clin Oncol. 2011;  29 532-543
    Google Scholar
  • 2 Bruggemann M, Schrauder A, Raff T. et al . Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18 – 20 September 2008.  Leukemia. 2010;  24 521-535
    Google Scholar
  • 3 Campana D. Progress of minimal residual disease studies in childhood acute leukemia.  Curr Hematol Malig Rep. 2010;  5 169-176
    Google Scholar
  • 4 Diller L. Clinical practice. Adult primary care after childhood acute lymphoblastic leukemia.  New Engl J Med. 2011;  365 1417-1424
    Google Scholar
  • 5 Foa R, Vitale A, Vignetti M. et al . Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.  Blood. 2011;  Sep. 19 [Epub ahead of print]
    Google Scholar
  • 6 Gökbuget N, Basara N, Baurmann H. et al . High single drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation.  Blood. 2011;  118 3504-3511
    Google Scholar
  • 7 Gökbuget N. Acute lymphoblastic leukemia in older patients.  Hematology Education (Education Programme for the 16th Congress of the EHA). 2011;  20-26
    Google Scholar
  • 8 Gökbuget N. Recommendations of the European Working Group for Adult ALL. Bremen: UNI-MED; 2011
    Google Scholar
  • 9 Gökbuget N. Salvage therapy of adult acute lymphoblastic leukemia. In: Faderl S, Kantarjian H Leukemias: Principles and Practice of Therapy. Oxford; Blackwell; 2011: 217-227
    Google Scholar
  • 10 Oliansky D M, Larson R A, Weisdorf D. et al . The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukemia: Update of the 2006 evidence-based review.  Biol Blood Marrow Transplant. 2011;  Jul. 29 [Epub ahead of print]
    Google Scholar
  • 11 Ottmann O G, Pfeifer H. Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).  Hematology Am Soc Hematol Educ Program. 2009;  371-2381
    Google Scholar
  • 12 Stock W, Douer D, Deangelo D J. et al . Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel.  Leuk Lymphoma. 2011;  Aug. 10 [Epub ahead of print]
    Google Scholar
  • 13 Topp M S, Kufer P, Gökbuget N. et al . Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.  J Clin Oncol. 2011;  29 2493-2498
    Google Scholar

Dr. Nicola Gökbuget

Medizinische Klinik II
Johann Wolfgang Goethe-Universität

Theodor-Stern-Kai 7

60590 Frankfurt

Phone: 069/6301-6364

Fax: 069/6301-7463

Email: goekbuget@em.uni-frankfurt.de

      >